Cargando…

Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing

OBJECTIVES: Our objective was to simulate the distribution of human papillomavirus (HPV) DNA test results from a 96-well microplate assay to identify results that may be consistent with well-to-well contamination, enabling programs to apply specific quality assurance parameters. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Beylerian, Emily N., Slavkovsky, Rose C., Holme, Francesca M., Jeronimo, Jose A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023602/
https://www.ncbi.nlm.nih.gov/pubmed/29570137
http://dx.doi.org/10.1097/LGT.0000000000000391
_version_ 1783335900952920064
author Beylerian, Emily N.
Slavkovsky, Rose C.
Holme, Francesca M.
Jeronimo, Jose A.
author_facet Beylerian, Emily N.
Slavkovsky, Rose C.
Holme, Francesca M.
Jeronimo, Jose A.
author_sort Beylerian, Emily N.
collection PubMed
description OBJECTIVES: Our objective was to simulate the distribution of human papillomavirus (HPV) DNA test results from a 96-well microplate assay to identify results that may be consistent with well-to-well contamination, enabling programs to apply specific quality assurance parameters. MATERIALS AND METHODS: For this modeling study, we designed an algorithm that generated the analysis population of 900,000 to simulate the results of 10,000 microplate assays, assuming discrete HPV prevalences of 12%, 13%, 14%, 15%, and 16%. Using binomial draws, the algorithm created a vector of results for each prevalence and reassembled them into 96-well matrices for results distribution analysis of the number of positive cells and number and size of cell clusters (≥2 positive cells horizontally or vertically adjacent) per matrix. RESULTS: For simulation conditions of 12% and 16% HPV prevalence, 95% of the matrices displayed the following characteristics: 5 to 17 and 8 to 22 total positive cells, 0 to 4 and 0 to 5 positive cell clusters, and largest cluster sizes of up to 5 and up to 6 positive cells, respectively. CONCLUSIONS: Our results suggest that screening programs in regions with an oncogenic HPV prevalence of 12% to 16% can expect 5 to 22 positive results per microplate in approximately 95% of assays and 0 to 5 positive results clusters with no cluster larger than 6 positive results. Results consistently outside of these ranges deviate from what is statistically expected and could be the result of well-to-well contamination. Our results provide guidance that laboratories can use to identify microplates suspicious for well-to-well contamination, enabling improved quality assurance.
format Online
Article
Text
id pubmed-6023602
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-60236022018-07-11 Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing Beylerian, Emily N. Slavkovsky, Rose C. Holme, Francesca M. Jeronimo, Jose A. J Low Genit Tract Dis Original Research Articles: Cervix and HPV OBJECTIVES: Our objective was to simulate the distribution of human papillomavirus (HPV) DNA test results from a 96-well microplate assay to identify results that may be consistent with well-to-well contamination, enabling programs to apply specific quality assurance parameters. MATERIALS AND METHODS: For this modeling study, we designed an algorithm that generated the analysis population of 900,000 to simulate the results of 10,000 microplate assays, assuming discrete HPV prevalences of 12%, 13%, 14%, 15%, and 16%. Using binomial draws, the algorithm created a vector of results for each prevalence and reassembled them into 96-well matrices for results distribution analysis of the number of positive cells and number and size of cell clusters (≥2 positive cells horizontally or vertically adjacent) per matrix. RESULTS: For simulation conditions of 12% and 16% HPV prevalence, 95% of the matrices displayed the following characteristics: 5 to 17 and 8 to 22 total positive cells, 0 to 4 and 0 to 5 positive cell clusters, and largest cluster sizes of up to 5 and up to 6 positive cells, respectively. CONCLUSIONS: Our results suggest that screening programs in regions with an oncogenic HPV prevalence of 12% to 16% can expect 5 to 22 positive results per microplate in approximately 95% of assays and 0 to 5 positive results clusters with no cluster larger than 6 positive results. Results consistently outside of these ranges deviate from what is statistically expected and could be the result of well-to-well contamination. Our results provide guidance that laboratories can use to identify microplates suspicious for well-to-well contamination, enabling improved quality assurance. Lippincott Williams & Wilkins 2018-07 2018-05-04 /pmc/articles/PMC6023602/ /pubmed/29570137 http://dx.doi.org/10.1097/LGT.0000000000000391 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the ASCCP. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Articles: Cervix and HPV
Beylerian, Emily N.
Slavkovsky, Rose C.
Holme, Francesca M.
Jeronimo, Jose A.
Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
title Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
title_full Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
title_fullStr Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
title_full_unstemmed Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
title_short Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing
title_sort statistical modeling for quality assurance of human papillomavirus dna batch testing
topic Original Research Articles: Cervix and HPV
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023602/
https://www.ncbi.nlm.nih.gov/pubmed/29570137
http://dx.doi.org/10.1097/LGT.0000000000000391
work_keys_str_mv AT beylerianemilyn statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting
AT slavkovskyrosec statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting
AT holmefrancescam statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting
AT jeronimojosea statisticalmodelingforqualityassuranceofhumanpapillomavirusdnabatchtesting